rs935756107
Positions:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 1P and 3B. PP2BP4_ModerateBP6
The NM_004408.4(DNM1):āc.2420C>Gā(p.Ser807Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000594 in 1,324,334 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00022 ( 0 hom., cov: 32)
Exomes š: 0.00064 ( 1 hom. )
Consequence
DNM1
NM_004408.4 missense
NM_004408.4 missense
Scores
1
4
14
Clinical Significance
Conservation
PhyloP100: 5.42
Genes affected
DNM1 (HGNC:2972): (dynamin 1) This gene encodes a member of the dynamin subfamily of GTP-binding proteins. The encoded protein possesses unique mechanochemical properties used to tubulate and sever membranes, and is involved in clathrin-mediated endocytosis and other vesicular trafficking processes. Actin and other cytoskeletal proteins act as binding partners for the encoded protein, which can also self-assemble leading to stimulation of GTPase activity. More than sixty highly conserved copies of the 3' region of this gene are found elsewhere in the genome, particularly on chromosomes Y and 15. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), DNM1. . Gene score misZ 5.1795 (greater than the threshold 3.09). Trascript score misZ 5.021 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, 31, undetermined early-onset epileptic encephalopathy, developmental and epileptic encephalopathy 31B, developmental and epileptic encephalopathy, Lennox-Gastaut syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.19125956).
BP6
Variant 9-128250826-C-G is Benign according to our data. Variant chr9-128250826-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 387422.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1, Benign=1}. Variant chr9-128250826-C-G is described in Lovd as [Likely_benign].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNM1 | NM_004408.4 | c.2420C>G | p.Ser807Cys | missense_variant | 21/22 | ENST00000372923.8 | NP_004399.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNM1 | ENST00000372923.8 | c.2420C>G | p.Ser807Cys | missense_variant | 21/22 | 1 | NM_004408.4 | ENSP00000362014.4 | ||
DNM1 | ENST00000634267.2 | c.2420C>G | p.Ser807Cys | missense_variant | 21/22 | 5 | ENSP00000489096.1 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 151980Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
33
AN:
151980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000642 AC: 753AN: 1172246Hom.: 1 Cov.: 31 AF XY: 0.000588 AC XY: 333AN XY: 566404
GnomAD4 exome
AF:
AC:
753
AN:
1172246
Hom.:
Cov.:
31
AF XY:
AC XY:
333
AN XY:
566404
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000217 AC: 33AN: 152088Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74352
GnomAD4 genome
AF:
AC:
33
AN:
152088
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74352
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | DNM1: PP2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 06, 2021 | - - |
Developmental and epileptic encephalopathy, 31A Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
DNM1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 30, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
T;.;.;.;.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;.;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L;.;L;.;L;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N;N;.;N;.;.;.
REVEL
Benign
Sift
Benign
D;D;D;D;.;D;.;.;.
Sift4G
Uncertain
T;T;T;T;T;T;T;T;T
Polyphen
P;.;P;.;.;.;.;P;.
Vest4
MutPred
Gain of catalytic residue at S807 (P = 0.0042);Gain of catalytic residue at S807 (P = 0.0042);Gain of catalytic residue at S807 (P = 0.0042);Gain of catalytic residue at S807 (P = 0.0042);.;Gain of catalytic residue at S807 (P = 0.0042);.;Gain of catalytic residue at S807 (P = 0.0042);Gain of catalytic residue at S807 (P = 0.0042);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at